GMP Vaccine & Viral Vector Production

ABL has an exceptional history in the development and production of preclinical and clinical viral-based biologics. From 30 years of groundbreaking work with HIV to supporting the latest gene therapy technologies, ABL offers a comprehensive portfolio of services for the effective design, development, production and testing of vaccine and gene therapy candidates.